← Back
$CORT All transactions

CORCEPT THERAPEUTICS INC

M 10b5-1 Plan

$ Value

$433K

Shares

20,000

Price

$22

Filed

Apr 8

Insider

Name

Guyer William

Title

Chief Development Officer

CIK

0001879013

Roles

Officer

Transaction Details

Transaction Date

2026-04-07

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

22,231

Footnotes

Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025 and 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. | This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction. | Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $40.85 to $41.30 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. | Fully exercisable.

Filing Info

Accession No.

0001193125-26-148497

Form Type

4

Issuer CIK

0001088856

Guyer William's History

Date Ticker Type Value
2026-04-07 CORT M $433K
2026-04-07 CORT $819K
2026-04-07 CORT M $0
2026-03-20 CORT M $255K
2026-03-20 CORT $424K
2026-03-20 CORT M $0
2026-02-03 CORT M $433K
2026-02-03 CORT $817K
2026-02-03 CORT M $0
2026-01-06 CORT M $433K

Other Insiders at CORT (90d)

Insider Bought Sold Last
BAKER G LEONARD JR 2026-01-27
WILSON JAMES N 2026-04-06
BELANOFF JOSEPH K
Chief Executive Officer
$1.3M 2026-03-25
Hunt Hazel
Chief Scientific Officer
2026-02-09
Guyer William
Chief Development Officer
$2.1M 2026-04-07